Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

FDA announces third recall of 2023 for troubled heart devices

This latest recall is due to a heightened risk that the devices will stop working with no warning. There have been 42 customer complaints reported so far. 

Medicare money payment physician

TAVR costs vary significantly from one hospital to the next

According to a new study of more than 119,000 hospitalizations, the costs associated with TAVR are far from consistent. 

SCAI President Sunil Rao explains what he saw as the top 5 interventional studies at ACC23. #SCAI #ACC #ACC23

5 studies that could make a big impact on interventional cardiology

SCAI President Sunil Rao, MD, spoke with us about some of the key interventional cardiology studies presented at ACC.23 in New Orleans. 

Thumbnail

New minimally invasive CLTI treatment helps save patients from amputation

The study’s primary endpoint, amputation-free survival after six months, was seen in 66.1% of CLTI patients who underwent transcatheter arterialization.

doctor fruits vegetables vegetarian diet

Mediterranean diet comes out on top in new comparison of popular ‘heart-healthy’ diets

Low-fat diets were also linked to certain benefits, including a reduced heart attack risk. 

Telehealth use plummets after pandemic highs

Use of the telehealth soared in 2020, but utilization has since fallen off a cliff after changing conditions of the COVID-19 pandemic. 

Thumbnail

CE mark suspended for troubled heart devices due to ongoing issues

The devices have been hit with multiple recalls in recent months. Those issues are now impacting sales outside of the United States as well.

Abbott Epic Max heart valve for aortic valve disease

Abbott’s new surgical solution for aortic valve disease gains FDA approval

The newly approved valve is the latest addition to Abbott’s Epic surgical valve platform.